Orléans, France

Yves-Michel Ginot

This inventor holds 1 USPTO granted patent. Top assignee: Les Laboratoires Servier. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yves-Michel Ginot. Retrieved from https://idiyas.com/inventor/yves-michel-ginot

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yves-Michel Ginot: Innovator in Medicinal Chemistry

Introduction

Yves-Michel Ginot is a notable inventor based in Orleans, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of pharmaceutical compounds. His work has led to advancements in the treatment of various medical conditions.

Latest Patents

Yves-Michel Ginot holds a patent for a β crystalline form of perindopril tert-butylamine salt. This compound is characterized by its unique powder X-ray diffraction data. The medicinal products containing this compound are useful as inhibitors of angiotensin I converting enzyme, which plays a crucial role in regulating blood pressure.

Career Highlights

Ginot is associated with Les Laboratoires Servier, a prominent pharmaceutical company. His work at Servier has focused on the development of innovative medicinal products that address critical health issues. His expertise in chemistry and pharmacology has been instrumental in advancing the company's research initiatives.

Collaborations

Throughout his career, Yves-Michel Ginot has collaborated with esteemed colleagues such as Bruno Pfeiffer and Gérard Coquerel. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Yves-Michel Ginot's contributions to medicinal chemistry and his innovative patent demonstrate his commitment to improving healthcare through scientific advancements. His work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…